Proceedings of International Conference on Applied Innovation in IT
2025/06/27, Volume 13, Issue 2, pp.825-832

Polymorphism of Genes in Iraqi Females with Type 2 Diabetes Mellitus


Asmaa M. Salih Almohaidi, Rana Hadi Saeed, Seemaa Fahad Mirza, Walaa A. Mohammed and Ibtisam Badday Hassan


Abstract: Diabetes Mellitus Type 2 (T2DM) is a global medical challenge, with cytokines playing a significant role in its developing. This study evaluates the frequency of polymorphisms in Interleukin-1α (IL-1α) at position -889 C/T (rs1800587), Interleukin-1β (IL-1β) at positions -511 C/T (rs16944) and +3962 C/T (rs1143634) and compared to healthy controls, diabetic patients exhibited an increased risk associated with the T allele of IL-1RL1-27609. In the study, which was conducted by Al-Yarmouk Teaching Hospital, 720 newly diagnosed Iraqi females with T2DM, aged 20-55 years, were included along with 240 age- and gender-matched healthy controls recruited from their own hospital. Genotyping was performed by using 49 patients and 40 normal after excluded others diseases and conducted the PCR-SSP assay, and results were validated by sequencing. Allele and genotype frequencies were analysed, and significant associations were identified. The findings revealed that the T allele and TT genotype of IL-1α (-889 C/T) significantly increased the risk of T2DM, while the C allele and CC genotype were protective. For IL-1β-511 C/T, the T allele acted as a protective factor, whereas the C allele elevated the risk of diabetes. No significant associations were observed for IL-1β +3962 C/T. Interestingly, polymorphisms in the IL-1RL1 receptor -27609 T/C showed that the T allele was related with increased susceptibility to diabetes, whereas the C allele was protective. Polymorphisms in IL-1α-889 C/T, IL-1β -511 C/T, and IL-1RL1 -27609 T/C appear to contribute to the genetic susceptibility to T2DM in Iraqi females. These findings highlight the potential role of interleukin signalling pathways in diabetes development. Further studies with larger, more diverse populations are recommended to confirm these results and explore their clinical implications.

Keywords: Diabetes Mellitus Type 2, Polymorphism, Interleukin-1α, Interleukin-1β, Interleukin Receptor, Genetic Susceptibility.

DOI: Under Indexing

Download: PDF

References:

  1. Y.-L. Shih, K.-T. Ho, C.-H. Tsao, Y.-H. Chang, M.-Y. Shiau, C.-N. Huang, and S.-C. Yang, "Role of cytokines in metabolism and type 2 diabetes mellitus," International Journal of Biomedical Laboratory Science, vol. 2, no. 1, pp. 1–6, 2013.
  2. A. M. S. Almohaidi, "Association among P-selectin, blood system ABO and family history in the sera of Iraqi Arab females patients with diabetes mellitus type II with hypertension," BAOJ Diabet., vol. 1, no. 003, 2015.
  3. A. Litmanovich, K. Khazim, and I. Cohen, "The role of interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice," Oncology and Therapy, vol. 6, pp. 109–127, 2018, doi: 10.1007/s40487-018-0089-z.
  4. E. D. Salman, "Genetic polymorphisms of interleukin-1 beta gene in association with multiple sclerosis in Iraqi patients," Iraqi Journal of Science, pp. 594–598, 2016.
  5. A. H. Ad’hiah, E. B. Hessan, and B. A. Shahab, "Interleukin-1 single nucleotide polymorphisms as risk factors for susceptibility of inflammatory bowel disease: an Iraqi Arab population-based study," Alexandria Journal of Medicine, vol. 55, no. 1, pp. 1–6, 2019, doi: 10.1080/20905068.2019.1585971.
  6. H. S. Saleh, I. A. AlRufaei, and E. S. Jawad, "Physiological change of interleukin-1 alpha (IL-1α) in Iraqi, Thi-Qar women with polycystic ovarian syndrome," University of Thi-Qar Journal of Science, vol. 10, no. 1, 2023.
  7. A. Nemetz, M. Toth, M. A. Garcia-Gonzalez, T. Zagoni, J. Feher, A. S. Pena, and Z. Tulassay, "Allelic variation at the interleukin 1β gene is associated with decreased bone mass in patients with inflammatory bowel diseases," Gut, vol. 49, no. 5, pp. 644–649, 2001, doi: 10.1136/gut.49.5.644.
  8. S. Kang, J. W. Kim, N. H. Park, Y. S. Song, S. Y. Park, S. B. Kang, and H. P. Lee, "Interleukin-1 beta-511 polymorphism and risk of cervical cancer," Journal of Korean Medical Science, vol. 22, no. 1, pp. 110–113, 2007, doi: 10.3346/jkms.2007.22.1.110.
  9. K. Tamura, G. Stecher, D. Peterson, A. Filipski, and S. Kumar, "MEGA6: Molecular evolutionary genetics analysis version 6.0," Molecular Biology and Evolution, vol. 30, no. 12, pp. 2725–2729, 2013, doi: 10.1093/molbev/mst197.
  10. M. G. Netea, B. J. Kullberg, and J. W. M. Van der Meer, "Circulating cytokines as mediators of fever," Clinical Infectious Diseases, vol. 31, suppl. 5, pp. S178–S184.
  11. Y. Liu, M. B. Costa, and C. Gerhardinger, "IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation," PLOS One, vol. 7, no. 5, p. e36949, 2012, doi: 10.1371/journal.pone.0036949.
  12. M. I. B. H. D. Maha and N. Falh, "A genetic polymorphism of interleukin-1a and interleukin 1 receptor antagonist gene with type 1 diabetes mellitus of Iraqi patients."
  13. O. Y. Gorlova, J. Ying, C. I. Amos, M. R. Spitz, B. Peng, and I. P. Gorlov, "Derived SNP alleles are used more frequently than ancestral alleles as risk-associated variants in common human diseases," Journal of Bioinformatics and Computational Biology, vol. 10, no. 2, p. 1241008, 2012, doi: 10.1142/S021972001241008X.
  14. J. Lachance, "Disease-associated alleles in genome-wide association studies are enriched for derived low frequency alleles relative to HapMap and neutral expectations," BMC Medical Genomics, vol. 3, no. 1, p. 57, 2010, doi: 10.1186/1755-8794-3-57.
  15. D. Fredman, S. L. Sawyer, L. Strömqvist, S. Mottagui-Tabar, K. K. Kidd, C. Wahlestedt, S. J. Chanock, and A. J. Brookes, "Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection," Human Mutation, vol. 27, no. 2, pp. 173–186, 2006, doi: 10.1002/humu.20299.
  16. Z. A. Hlail and K. I. A. Mohammed, "Immunological detection of interleukin-1alpha (IL-1α) in Iraqi women with polycystic ovarian syndrome," SAR Journal of Medical Biochemistry, vol. 3, no. 3, pp. 39–42, 2022.
  17. K. Puri, M. Chhokra, V. Dodwad, and N. Puri, "Association of interleukin-1 α (–889) gene polymorphism in patients with generalized aggressive and chronic periodontitis," Dental Research Journal, vol. 12, no. 1, p. 76, 2015, doi: 10.4103/1735-3327.150322.
  18. L. Q. Abdulhameed and M. W. M. Alzubaidy, "Association between polymorphism of the CRP gene rs1130864 and hypertension among Iraqi hypertensive patients," Advances in Life Sciences, vol. 10, no. 2, pp. 157–160, 2023.
  19. L. L. de Moraes Marchiori et al., "Interleukin-1 alpha gene polymorphism (IL-1α) and susceptibility to tinnitus in the elderly," Noise & Health, vol. 21, no. 99, p. 77, 2019, doi: 10.4103/nah.NAH_41_18.
  20. R. Zhao, H. Zhou, and S. B. Su, "A critical role for interleukin-1β in the progression of autoimmune diseases," International Immunopharmacology, vol. 17, no. 3, pp. 658–669, 2013.
  21. A. K. Tripathi, S. Shukla, J. K. Tripathi, R. D. Saket, S. Kol, P. Mishra, U. K. Chauhan, and M. Indurkar, "Association of genetic polymorphism of inflammatory genes (IL-1β and IL-4) with diabetes type 2," Enliven: Journal of Genetic Molecular and Cellular Biology, vol. 1, no. 1, p. 004, 2015.
  22. S. I. Tayel, E. A. M. Fouda, E. I. Elshayeb, A. R. A. Eldakamawy, and S. M. El-kousy, "Biochemical and molecular study on interleukin-1β gene expression and relation of single nucleotide polymorphism in promoter region with type 2 diabetes mellitus," Journal of Cellular Biochemistry, vol. 119, no. 7, pp. 5343–5349, 2018.
  23. J. Jiao, Z. Wang, Y. Guo, J. Liu, X. Huang, X. Ni, D. Gao, L. Sun, X. Zhu, and Q. Zhou, "Association between IL-1β (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis," PeerJ, vol. 9, p. e12384, 2021, doi: 10.7717/peerj.12384.
  24. Z. M. Al-Maamouri and H. A. H. Al-Saadi, "Isolation and antimicrobial susceptibility patterns of bacterial pathogens causing respiratory tract infections in children," International Journal of Applied Sciences, vol. 1, no. 3, pp. 42–49, Dec. 2024, doi: 10.69923/p9tdez63.
  25. S. Abtahi, A. Farazmand, M. Mahmoudi, A. Ashraf-Ganjouei, A. Javinani, B. Nazari, H. Kavosi, A. A. Amirzargar, A. R. Jamshidi, and F. Gharibdoost, "IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis," International Journal of Immunogenetics, vol. 42, no. 6, pp. 423–427, 2015, doi: 10.1111/iji.12200.
  26. I. Ben Dhifallah, K. Ayouni, G. Najjar, H. Chelbi, A. Sadraoui, W. Hammami, H. Touzi, and H. Triki, "Interleukin IL-1B gene polymorphism in Tunisian patients with chronic hepatitis B infection: association with replication levels," Microbiology and Immunology, vol. 64, no. 7, pp. 512–519, 2020, doi: 10.1111/1348-0421.12796.
  27. J. Fischer, S. Long, E. Koukoulioti, T. Müller, B. Fueloep, R. Heyne, M. Eslam, J. George, F. Finkelmeier, and O. Waidmann, "Association of common polymorphisms in the interleukin-1 beta gene with hepatocellular carcinoma in Caucasian patients with chronic hepatitis B," Pathogens, vol. 12, no. 1, p. 54, 2022, doi: 10.3390/pathogens12010054.


    HOME

       - Conference
       - Journal
       - Paper Submission to Journal
       - For Authors
       - For Reviewers
       - Important Dates
       - Conference Committee
       - Editorial Board
       - Reviewers
       - Last Proceedings


    PROCEEDINGS

       - Volume 13, Issue 2 (ICAIIT 2025)
       - Volume 13, Issue 1 (ICAIIT 2025)
       - Volume 12, Issue 2 (ICAIIT 2024)
       - Volume 12, Issue 1 (ICAIIT 2024)
       - Volume 11, Issue 2 (ICAIIT 2023)
       - Volume 11, Issue 1 (ICAIIT 2023)
       - Volume 10, Issue 1 (ICAIIT 2022)
       - Volume 9, Issue 1 (ICAIIT 2021)
       - Volume 8, Issue 1 (ICAIIT 2020)
       - Volume 7, Issue 1 (ICAIIT 2019)
       - Volume 7, Issue 2 (ICAIIT 2019)
       - Volume 6, Issue 1 (ICAIIT 2018)
       - Volume 5, Issue 1 (ICAIIT 2017)
       - Volume 4, Issue 1 (ICAIIT 2016)
       - Volume 3, Issue 1 (ICAIIT 2015)
       - Volume 2, Issue 1 (ICAIIT 2014)
       - Volume 1, Issue 1 (ICAIIT 2013)


    PAST CONFERENCES

       ICAIIT 2025
         - Photos
         - Reports

       ICAIIT 2024
         - Photos
         - Reports

       ICAIIT 2023
         - Photos
         - Reports

       ICAIIT 2021
         - Photos
         - Reports

       ICAIIT 2020
         - Photos
         - Reports

       ICAIIT 2019
         - Photos
         - Reports

       ICAIIT 2018
         - Photos
         - Reports

    ETHICS IN PUBLICATIONS

    ACCOMODATION

    CONTACT US

 

        

         Proceedings of the International Conference on Applied Innovations in IT by Anhalt University of Applied Sciences is licensed under CC BY-SA 4.0


                                                   This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License


           ISSN 2199-8876
           Publisher: Edition Hochschule Anhalt
           Location: Anhalt University of Applied Sciences
           Email: leiterin.hsb@hs-anhalt.de
           Phone: +49 (0) 3496 67 5611
           Address: Building 01 - Red Building, Top floor, Room 425, Bernburger Str. 55, D-06366 Köthen, Germany

        site traffic counter

Creative Commons License
Except where otherwise noted, all works and proceedings on this site is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.